Literature DB >> 2187334

Subtle and atypical cobalamin deficiency states.

R Carmel1.   

Abstract

Evidence for cobalamin (vitamin B12) deficiency usually involves some combination of low serum cobalamin levels, clinical abnormalities (classically, megaloblastic anemia and neurologic defects), metabolic abnormalities, and response to therapy. However, cobalamin deficiency may often display few of the expected clinical findings. Identification of the underlying cause is also important in the diagnosis of deficiency, and its value may be particularly great when the expression of deficiency is subtle. The cause of cobalamin deficiency is usually malabsorptive, but may sometimes be limited to malabsorption of food cobalamin while free cobalamin is absorbed normally. Nongastroenterologic entities may sometimes also be found. All of these considerations allow the proposal of four patterns of cobalamin deficiency. The first type is classical deficiency; typical megaloblastic anemia with or without neurologic dysfunction occurs because of classical cobalamin malabsorption such as lack of intrinsic factor (pernicious anemia). The second type consists of classical cobalamin malabsorption in which the cobalamin deficiency is expressed subtly rather than in classical fashion. There is no megaloblastic anemia and sometimes the only evidence of deficiency may be metabolic. In the third type, cobalamin deficiency is expressed classically but is attributable to a subtle or atypical cause, such as food-cobalamin malabsorption. In the fourth type, deficiency is both expressed subtly and arises from subtle or atypical causes. Such presentations require further investigation but are a challenging expansion of our understanding and recognition of cobalamin deficiency.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187334     DOI: 10.1002/ajh.2830340206

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

1.  Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification.

Authors:  Martha Savaria Morris; Paul F Jacques; Irwin H Rosenberg; Jacob Selhub
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

Review 2.  Vitamin supplementation therapy in the elderly.

Authors:  J E Thurman; A D Mooradian
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

3.  Vitamin B12 deficiency in Australian residential aged care facilities.

Authors:  C Mirkazemi; G M Peterson; P C Tenni; S L Jackson
Journal:  J Nutr Health Aging       Date:  2012-03       Impact factor: 4.075

4.  Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.

Authors:  Refael Segal; Yehuda Baumoehl; Ori Elkayam; David Levartovsky; Irena Litinsky; Daphna Paran; Irena Wigler; Beni Habot; Arthur Leibovitz; Ben Ami Sela; Dan Caspi
Journal:  Rheumatol Int       Date:  2003-04-29       Impact factor: 2.631

5.  Helicobacter pylori infection and food-cobalamin malabsorption.

Authors:  R Carmel; G I Perez-Perez; M J Blaser
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

6.  In vitamin B12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations.

Authors:  Jacob Selhub; Martha Savaria Morris; Paul F Jacques
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-04       Impact factor: 11.205

7.  Oral vitamin B12 for patients suspected of subtle cobalamin deficiency: a multicentre pragmatic randomised controlled trial.

Authors:  Bernard Favrat; Paul Vaucher; Lilli Herzig; Bernard Burnand; Giuseppa Ali; Olivier Boulat; Thomas Bischoff; François Verdon
Journal:  BMC Fam Pract       Date:  2011-01-13       Impact factor: 2.497

Review 8.  Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II.

Authors:  Ralph Carmel
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.